Alnylam Pharmaceuticals, Inc. (ALNY)
333.50
-5.91
(-1.74%)
USD |
NASDAQ |
Apr 15, 16:00
333.50
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap : 44.23B for April 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 154.64B |
| Eli Lilly & Co. | 810.27B |
| Ionis Pharmaceuticals, Inc. | 12.69B |
| Regeneron Pharmaceuticals, Inc. | 79.70B |
| Sarepta Therapeutics, Inc. | 2.281B |
Market Cap Related Metrics
| PE Ratio | 147.76 |
| PS Ratio | 11.99 |
| Price to Book Value | 56.05 |
| Price to Free Cash Flow | 95.66 |
| Price | 333.50 |
| Earnings Yield | 0.68% |
| Operating PE Ratio | 88.75 |
| Normalized PE Ratio | 133.94 |